Results 91 to 100 of about 29,482 (220)

Scalp Microbiome Alterations in Androgenetic Alopecia: Patterns and Emerging Mechanistic Insights

International Journal of Dermatology, EarlyView.
Summary of the microbiome‐lipid‐microinflammation axis in androgenetic alopecia (AGA). Altered sebaceous gland activity, shifts in microbial abundance on the scalp and hair follicle, and follicular microinflammation interact bidirectionally, each reinforcing the others.
Aditya K. Gupta, Elizabeth M. Teasell, Amanda Liddy, Vasiliki Economopoulos   +3 more
wiley   +1 more source

Ocular surface changes in moderate-to-severe acne vulgaris [PDF]

International Journal of Ophthalmology
AIM: To investigate ocular surface disorders and tear function changes in patients with acne vulgaris and explore the potential relationship between acne vulgaris and dry eye.
Ci-Yi Pan, Dong-Jie Sun, Han-Ling Li, Li Ma, Min Zhang, Song-Yuan Tang, Hui Zhang   +6 more
doaj   +1 more source

Hubungan Kepribadian Tipe-d Dengan Koping Klien Akne Vulgaris Di Jurusan Keperawatan Politeknik Kesehatan Kemenkes Manado [PDF]

, 2014
; This study aims to identify the relationship of type-D personality with clients coping acne vulgaris. The research method using descriptive analytic cross sectional design, the 120 respondents polytechnic nursing students of Department of Health MoH ...
Lumi, F. (Femmy), Ponge, S. (Selny), Tangka, J. W. (Jon)   +2 more
core  

Reply to: Superficial Pustular Folliculitis of the Face and Neck—A Non‐Infectious Eruption Responding to Topical Steroids

JEADV Clinical Practice, EarlyView.
Jinfeng Liu, Zhuokun Ran, Suhong Shi, Wei Hua   +3 more
wiley   +1 more source

Efficacy and safety of brodalumab in palmoplantar pustulosis: A 68‐week randomized Phase 3 trial

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This open‐label study is a continuation of the 16‐week double‐blind, Phase 3 trial assessing the efficacy and safety of brodalumab 210 mg subcutaneously, till a 68‐week extension period. Continued improvement was seen in the PPPASI 50/75/90 responses, PPPSI scores, PGA 0/1 responses and DLQI. Abstract Background The efficacy and safety of brodalumab in
Masamoto Murakami, Yukari Okubo, Satomi Kobayashi, Natsuko Kikuta, Yoshiumi Ouchi, Kenta Shishido, Tadashi Terui   +6 more
wiley   +1 more source

Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne. [PDF]

, 2019
BACKGROUND: Acne vulgaris often affects the face, shoulders, chest, and back, but treatment of nonfacial acne has not been rigorously studied. OBJECTIVES: Assess the safety and efficacy of trifarotene 50 μg/g cream, a novel topical retinoid, in moderate ...
Ahmad, Faiz, Alió Saenz, Alessandra, Blume-Peytavi, Ulrike, Del Rosso, James, Gooderham, Melinda, Graeber, Michael, Johnson, Sandra, Lynde, Charles, Parish, Lawrence, Popp, Georg, Sanchez Colon, Nestor, Stein Gold, Linda, Tan, Jerry, Thiboutot, Diane, Weglovska, Jolanta, Weiss, Jonathan, Witkowska, Dagmara   +16 more
core   +1 more source

Update of the EuroGuiDerm evidence‐based guideline for the treatment of acne—Short version

Journal of the European Academy of Dermatology and Venereology, EarlyView.
The 2025 EuroGuiDerm guideline update provides evidence‐based recommendations for acne management, addressing systemic antibiotics, systemic isotretinoin, hormonal therapies including spironolactone and contraceptives, and new topical agents. Key considerations include treatment duration, safety, pregnancy‐specific guidance and minimizing antibiotic ...
Alexander Nast, Bassel H. Al Wattar, Marie Beylot Barry, Holger Brüggemann, Zrinka Bukvić Mokos, Dawn M. Caruana, Klaus Degitz, Clio Dessinioti, Brigitte Dréno, Rieke J. B. Driessen, Harald Gollnick, Merete Hædersdal, Alexander Katoulis, Severin Läuchli, Julien Lambert, Alison M. Layton, Giuseppe Micali, Falk R. Ochsendorf, Thozhukat Sathyapalan, Katarina Zak Stangeland, Simon Francis Thomsen, Daniel Töröcsik, Antonia Pennitz   +22 more
wiley   +1 more source

Research progress on the correlation between squalene and acne vulgaris

Pifu-xingbing zhenliaoxue zazhi
Acne vulgaris is a common inflammatory skin disease involving the pilosebaceous unit. Squalene in sebum serves as a key mediator in the pathogenesis of acne.
WEI Yun, LIN Jiaxin, WANG Yuying, ZHOU Li, WANG Jing, HUANG Hu   +5 more
doaj   +1 more source

Prevalence rate, risk factors of acne vulgaris and its impact on the quality of life among teen-agers in Qena city, Upper Egypt

SVU - International Journal of Medical Sciences, 2019
Objectives: determine the prevalence of acne vulgaris among teen-agers in Qena city, determine the risk factors of acne vulgaris, and determine the effect of acne vulgaris on the quality of life among teen-agers in Qena city.
Ahmed M. Mahmoud, Ahmed F. Hamed, Eisa M. Hegazy, Eslam A. Sadek   +3 more
doaj   +1 more source

The association of depression, loneliness and internet addiction levels in patients with acne vulgaris

BioPsychoSocial Medicine, 2020
Background Acne vulgaris is a very common skin disorder that has negative effects on the mood, self image and social relations of the patients. We want to evaluate the effects of acne vulgaris and its severity on depression, loneliness, internet ...
Coşkun Öztekin, Aynure Öztekin
doaj   +1 more source